Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2015 / Article

Case Report | Open Access

Volume 2015 |Article ID 703240 | https://doi.org/10.1155/2015/703240

Karuna Tadepalli, Pradeep Kumar Gupta, Dinesh P. Asati, Debasis Biswas, "Onychomycosis due to Cunninghamella bertholletiae in an Immunocompetent Male from Central India", Case Reports in Infectious Diseases, vol. 2015, Article ID 703240, 4 pages, 2015. https://doi.org/10.1155/2015/703240

Onychomycosis due to Cunninghamella bertholletiae in an Immunocompetent Male from Central India

Academic Editor: Paola Di Carlo
Received08 Sep 2015
Revised02 Nov 2015
Accepted03 Nov 2015
Published12 Nov 2015

Abstract

Onychomycosis is a fungal infection of nails seen frequently in immune competent and immune compromised patients due to dermatophytes, Candida spp., Fusarium spp., Scopulariopsis brevicaulis, Penicillium spp., and Aspergillus spp. We report a case of onychomycosis in a young immunocompetent male who presented onycholysis of a solitary nail without inflammation. The etiological agent was diagnosed to be Cunninghamella bertholletiae, a fungus pertaining to the order Mucorales (subdivision Mucoromycotina) and known for some of the invasive lesions among immunocompromised patients. This case demonstrates the association of onychomycosis with Cunninghamella bertholletiae in an immune competent individual, not reported so far.

1. Introduction

Cunninghamella bertholletiae (order Mucorales, subdivision Mucoromycotina) is a saprophytic, ubiquitous fungus found in soil [1]. Although C. bertholletiae is known to be the only clinically relevant species in the Cunninghamellaceae family [24], other species were recently reported as human pathogens [5]. Although it was first isolated from Brazilian soil samples by Stadel in 1911, C. bertholletiae was recently recognized as a cosmopolitan soil organism [6]. The first case of C. bertholletiae infection was described in 1958 from a patient with lymph sarcoma and immunosuppressive therapy. C. bertholletiae remains a rare cause of mucormycosis and has been described almost exclusively (98%) for immunosuppressed hosts [6]. We report a rare case of onychomycosis due to C. bertholletiae in an immune competent patient.

2. Case Report

A 30-year-old male patient residing in Bhopal (Central India) presented to the dermatology department with a lesion in the nail of the left middle finger (Figure 1) for about five years, with history of traumatic injury and no previous use of antifungal therapy. He complained only about the cosmetic aspect as improper growth and unhealthy look of the nail. Professionally, he was involved with mycology laboratory work for few years in United Kingdom and nurtured his hobby of gardening with bare hands very frequently and then returned to India and is continuing with his work.

On local examination he presented onycholysis and onychodystrophy, with no apparent thickening or inflammation of ungueal bed. There was no history of other symptoms except for nail dystrophy. Systemic examination was normal.

On mycological examination, fungal elements were observed in 20% potassium hydroxide (KOH) preparations as broad hyaline sparsely septate hyphae (Figure 2). Nail specimen was cultured on Sabouraud dextrose agar (SDA) and incubated at 30°C. A rapid growth within 48 hours as wooly white mycelia was observed with reverse pale (Figure 3) and almost filling the whole plate within 72 hours. This mature growth turned grey and further darkened with age, with a reverse remaining pale (Figure 4). On performing lactophenol cotton blue (LPCB) wet mount of the fungus broad, hyaline, and sparsely septate hyphae with branching sporangiophores and terminal vesicle covered with spine-like denticles, and each denticle with a single sporangiolum, later forming each sporangiospore covering the entire surface of the vesicle, was seen. Sporangiospores were spherical to ovoidal (Figures 5(a) and 5(b)).

After the first diagnosis, a second sample was taken; the laboratory procedures were repeated. The SDA slants were incubated at 30°C and at 45°C. Both slants showed similar morphology within 3 days of incubation (Figure 6). On repeating LPCB wet mount and microscopic observation similar structural details were seen, suggesting the fungal growth to be Cunninghamella bertholletiae.

The patient was advised to apply Ciclopirox topical solution 8% along with oral itraconazole 200 mg/twice a day for one week. Seeing no response the patient was advised for surgical removal of nail, but the patient did not show up for the treatment.

3. Discussion

Primary cutaneous and cutaneoarticular cases of mucormycosis caused by C. bertholletiae were reported following percutaneous inoculation or trauma in patients with diabetes mellitus, renal transplant recipients, and an i.v. drug abuser with AIDS [6]. Cutaneous C. bertholletiae infection was also described for a patient with leukemia who died 18 days after development of a necrotic skin lesion following the use of elastic adhesive tape surrounding a pleural effusion damage site [7]. Cutaneous C. bertholletiae infections typically appear as necrotic lesions, with occasional creamy white exudates and granules [6]. There are no reports of onychomycosis documented so far due to Cunninghamella spp.

Cunninghamella spp. can be found at the lab as environmental contaminants [4]. However, an isolate of C. bertholletiae from any clinical material should be analyzed carefully because it is not an ordinary contaminant. In at least two cases, misinterpretation of mycological laboratory findings caused fatal delay or lack of treatment [8, 9]. In our case, presence of fungal elements on direct KOH wet mount could be correlated with the results of the culturing. Also, repeated samples showing the same results suggest the possibility of such saprobic fungal infections particularly in chronic presentations in immunocompetent patients.

C. bertholletiae is a fast-growing mold that can grow at room temperature to 45°C.

C. bertholletiae grows at temperatures above 40°C, which distinguishes it from C. elegans. The species appears as branched sporangiophores terminating at a swollen, terminal vesicle with spherical, ovoidal, or ellipsoidal sporangioles [4, 1012].

Percutaneous inoculation of C. bertholletiae, although less common, has been described from the inpatient, outpatient, and community settings, following pleural taps, peritoneal dialysis, use of blood glucose self-monitoring equipment, and insulin injection [6].

Traumatic injuries have been associated with C. bertholletiae infections, including motor vehicle accidents, abrasion occurring while fishing in a patient with leukemia, and nondescript trauma in a human immunodeficiency virus-positive patient [6]. Recently, a rare first case of corneal ulcer caused by Cunninghamella spp. following trauma by a stick in an immunocompetent patient has been reported from India [13].

The most common underlying conditions described for patients with C. bertholletiae infections are leukemia (51%), diabetes mellitus (19%), nonmalignant haematological diseases (16%), deferoxamine-based therapy (12%), organ transplantation (9%), asplenia (7%), hepatic cirrhosis (2%), AIDS, i.v. drug abuse (2%), and chronic pharmacological immunosuppression for treatment of autoimmune disease (2%) [6].

Only two descriptions of C. bertholletiae or Cunninghamella species infection have been reported for seemingly immunocompetent patients [9, 14].

Sivakumar et al. from India reported a case of C. bertholletiae pulmonary infection in a 42-year-old male patient who developed graft-versus-host disease following bone marrow transplantation [15].

Ours is rare association of C. bertholletiae and onychomycosis in an Indian immunocompetent young male; no case is reported so far.

4. Conclusion

The laboratory diagnosis of C. bertholletiae onychomycosis, as well as with other nondermatophyte fungal infections, should always necessarily be confirmed whether the fungus is the real etiologic agent of the onychomycosis, by collecting repeated fresh samples and processing for KOH wet mount examination and culture for morphological examination, or wherever the facilities are available followed by a final molecular identification by ITS region amplification and sequencing.

Ethical Approval

Institutional Human Ethics Committee of All India Institute of Medical Sciences Bhopal approved the case study and approval reference number is IHEC-LOP/2015/IM0047.

The authors declare the following. (1) They have obtained written, informed consent for the publication of the details relating to the patient(s) in this report. (2) All possible steps have been taken to safeguard the identity of the patient(s). (3) This submission is compliant with the requirements of local research ethics committees.

Conflict of Interests

The authors declare that they have no competing interests.

Acknowledgment

The authors thank Mr. Robin Sharma for technical work.

References

  1. V. Rickerts, A. Böhme, A. Viertel et al., “Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients,” Clinical Infectious Diseases, vol. 31, no. 4, pp. 910–913, 2000. View at: Publisher Site | Google Scholar
  2. D. P. Kontoyianis, S. Vartivarian, E. J. Anaissie, G. Samonis, G. P. Bodey, and M. Rinaldi, “Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review,” Clinical Infectious Diseases, vol. 18, no. 6, pp. 925–928, 1994. View at: Publisher Site | Google Scholar
  3. K. Lemmer, H. Losert, V. Rickerts et al., “Molecular biological identification of Cunninghamella spec,” Mycoses, vol. 45, supplement 1, pp. 31–36, 2002. View at: Google Scholar
  4. J. A. Ribes, C. L. Vanover-Sams, and D. J. Baker, “Zygomycetes in human disease,” Clinical Microbiology Reviews, vol. 13, no. 2, pp. 236–301, 2000. View at: Publisher Site | Google Scholar
  5. E. Alvarez, D. A. Sutton, J. Cano et al., “Spectrum of zygomycete species identified in clinically significant specimens in the United States,” Journal of Clinical Microbiology, vol. 47, no. 6, pp. 1650–1656, 2009. View at: Publisher Site | Google Scholar
  6. M. Z. R. Gomes, R. E. Lewis, and D. P. Kontoyiannis, “Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species,” Clinical Microbiology Reviews, vol. 24, no. 2, pp. 411–445, 2011. View at: Publisher Site | Google Scholar
  7. K. Motohashi, S. Ito, M. Hagihara, A. Maruta, Y. Ishigatsubo, and H. Kanamori, “Cutaneous zygomycosis caused by Cunninghamella bertholletiae in a patient with chronic myelogenous leukemia in blast crisis,” American Journal of Hematology, vol. 84, no. 7, pp. 447–448, 2009. View at: Publisher Site | Google Scholar
  8. M. R. McGinnis, D. H. Walker, I. E. Dominy, and W. Kaplan, “Zygomycosis caused by Cunninghamella bertholletiae: clinical and pathologic aspects,” Archives of Pathology & Laboratory Medicine, vol. 106, no. 6, pp. 282–286, 1982. View at: Google Scholar
  9. S. Zeilender, D. Drenning, F. L. Glauser, and D. Bechard, “Fatal Cunninghamella bertholletiae infection in an immunocompetent patient,” Chest, vol. 97, no. 6, pp. 1482–1483, 1990. View at: Publisher Site | Google Scholar
  10. A. E. Reed, B. A. Body, M. B. Austin, and H. F. Frierson Jr., “Cunninghamella bertholletiae and Pneumocystis carinii pneumonia as a fatal complicationof chronic lymphocytic leukemia,” Human Pathology, vol. 19, no. 12, pp. 1470–1472, 1988. View at: Publisher Site | Google Scholar
  11. E. Righi, C. G. Giacomazzi, V. Lindstrom et al., “A case of Cunninghamella bertholettiae rhino-cerebral infection in a leukaemic patient and review of recent published studies,” Mycopathologia, vol. 165, no. 6, pp. 407–410, 2008. View at: Publisher Site | Google Scholar
  12. I. Weitzman and M. Y. Crist, “Studies with clinical isolates of Cunninghamella. I. Mating behavior,” Mycologia, vol. 71, no. 5, pp. 1024–1033, 1979. View at: Publisher Site | Google Scholar
  13. S. V. Bhandary, H. Vijayapai, L. G. Rao, and P. P. Yegneswaran, “Cunninghamella spinosum fungal corneal ulcer: first case report,” Indian Journal of Ophthalmology, vol. 62, no. 3, pp. 375–376, 2014. View at: Publisher Site | Google Scholar
  14. N. S. S. Jayasuriya, W. M. Tilakaratne, E. A. P. D. Amaratunga, and M. K. B. Ekanayake, “An unusual presentation of rhinofacial zygomycosis due to Cunninghamella sp. in an immunocompetent patient: a case report and literature review,” Oral Diseases, vol. 12, no. 1, pp. 67–69, 2006. View at: Publisher Site | Google Scholar
  15. S. Sivakumar, M. S. Mathews, and B. George, “Cunninghamella pneumonia in postbone marrow transplant patient: first case report from India,” Mycoses, vol. 48, no. 5, pp. 360–362, 2005. View at: Publisher Site | Google Scholar

Copyright © 2015 Karuna Tadepalli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1219
Downloads475
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.